AWM
TMO icon

AE Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

AE Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.63M Buy
5,350
+93
+2% +$50.5K 0.01% 569
2025
Q4 		$3.05M Sell
5,257
-63,724
-92% -$36M 0.02% 495
2025
Q3 		$33.5M Buy
68,981
+5,334
+8% +$2.48M 0.21% 107
2025
Q2 		$25.8M Buy
63,647
+2,702
+4% +$1.13M 0.19% 121
2025
Q1 		$30.3M Buy
60,945
+956
+2% +$518K 0.26% 93
2024
Q4 		$31.2M Buy
59,989
+4,426
+8% +$2.43M 0.26% 90
2024
Q3 		$34.4M Buy
55,563
+6,006
+12% +$3.56M 0.31% 81
2024
Q2 		$27.4M Buy
49,557
+5,247
+12% +$3.01M 0.27% 85
2024
Q1 		$25.8M Sell
44,310
-313
-0.7% -$176K 0.29% 86
2023
Q4 		$24.4M Buy
44,623
+10,336
+30% +$5M 0.12% 186
2023
Q3 		$17.4M Buy
34,287
+1,841
+6% +$981K 0.1% 213
2023
Q2 		$16.9M Buy
32,446
+9,725
+43% +$5.25M 0.1% 237
2023
Q1 		$13.1M Sell
22,721
-1,777
-7% -$1M 0.08% 285
2022
Q4 		$13.5M Sell
24,498
-1,131
-4% -$599K 0.1% 245
2022
Q3 		$13M Buy
25,629
+7,925
+45% +$4.44M 0.1% 206
2022
Q2 		$9.62M Buy
17,704
+2,423
+16% +$1.33M 0.08% 280
2022
Q1 		$9.03M Buy
15,281
+1,057
+7% +$607K 0.06% 307
2021
Q4 		$9.49M Buy
14,224
+1,330
+10% +$830K 0.07% 274
2021
Q3 		$7.37M Sell
12,894
-1,822
-12% -$1M 0.06% 292
2021
Q2 		$7.42M Sell
14,716
-6,258
-30% -$2.95M 0.06% 276
2021
Q1 		$9.57M Buy
20,974
+2,883
+16% +$1.38M 0.1% 212
2020
Q4 		$8.43M Sell
18,091
-298
-2% -$140K 0.1% 207
2020
Q3 		$8.12M Buy
18,389
+5,998
+48% +$2.48M 0.12% 165
2020
Q2 		$4.49M Buy
12,391
+7,505
+154% +$2.52M 0.07% 236
2020
Q1 		$1.39M Buy
4,886
+573
+13% +$181K 0.03% 406
2019
Q4 		$1.4M Buy
4,313
+419
+11% +$127K 0.03% 450
2019
Q3 		$1.13M Buy
3,894
+732
+23% +$210K 0.03% 417
2019
Q2 		$929K Buy
3,162
+1,695
+116% +$467K 0.03% 423
2019
Q1 		$402K Buy
1,467
+317
+28% +$78.9K 0.03% 395
2018
Q4 		$257K Buy
1,150
+178
+18% +$41.8K 0.04% 388
2018
Q3 		$237K Buy
+972
New +$224K 0.01% 513

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AE Wealth Management's TMO Position: Q1 2026 in Review

AE Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q1 2026, buying an estimated $50.5K and bringing the position to 5,350 shares worth $2.63M. The position accounts for 0.01% of the portfolio, ranked #569.

AE Wealth Management first reported a position in TMO in Q3 2018 and has held it in 31 quarters since. The position peaked at $34.4M in Q3 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • AE Wealth Management held 5,350 shares of Thermo Fisher Scientific worth $2.63M as of Q1 2026.
  • AE Wealth Management bought 93 Thermo Fisher Scientific shares in Q1 2026, an estimated $50.5K.
  • Thermo Fisher Scientific made up 0.01% of AE Wealth Management's portfolio in Q1 2026, its #569 holding.
  • AE Wealth Management first reported a position in Thermo Fisher Scientific in Q3 2018 and has held it in 31 quarters since.
  • AE Wealth Management's Thermo Fisher Scientific position peaked at $34.4M in Q3 2024.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on AE Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.